How AI is De-Risking Drug Development and Companion Diagnostics

Arora and Moore in The Scientist: The path to bringing a new drug to market is increasingly complex and costly, with development costs now exceeding $2 billion and timelines approaching a decade. 1,2 The stakes have never been higher—demanding new models, new technologies, and new thinking to reduce.